Snowden Capital Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Snowden Capital Advisors's DXCM Position: Q1 2026 in Review
Snowden Capital Advisors increased its DexCom (DXCM) stake by 2.5% in Q1 2026, buying an estimated $8.5K and bringing the position to 4,932 shares worth $310K. The position accounts for 0.01% of the portfolio, ranked #1009.
Snowden Capital Advisors first reported a position in DXCM in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.02M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Snowden Capital Advisors held 4,932 shares of DexCom worth $310K as of Q1 2026.
- Snowden Capital Advisors bought 122 DexCom shares in Q1 2026, an estimated $8.5K.
- DexCom made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #1009 holding.
- Snowden Capital Advisors first reported a position in DexCom in Q2 2021 and has held it in 20 quarters since.
- Snowden Capital Advisors's DexCom position peaked at $1.02M in Q1 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.